Clival chordoma of the nasal septum secondary to surgical pathway seeding

J Peyton Hines1, Mary G Ashmead2, Scott P Stringer2

  • 1Department of Otolaryngology, Mayo School of Graduate Medical Education, Phoenix, AZ, USA.

Abstract

Insights

Tumor seeding in the nasal septum is a rare complication of transseptal surgery for clival chordoma. This case highlights the importance of considering this treatment failure pathway.

Area of Science:

  • Neurosurgery
  • Oncology
  • Pathology

Background:

  • Clival chordomas are rare bone tumors originating in the skull base.
  • Transseptal approaches are utilized for surgical resection but carry potential risks.

Observation:

  • A patient with a history of clival chordoma treated with transseptal resection developed an intranasal mass.
  • Imaging revealed a nasal septum mass, confirmed as chordoma on biopsy.
  • This was presumed to be secondary to tumor seeding during prior surgical attempts.

Findings:

  • Tumor seeding along the surgical pathway is an infrequent cause of treatment failure in clival chordoma resection.
  • This case presents a rare instance of implanted metastases in the nasal septum.

Implications:

  • Surgeons must weigh the risk of septal seeding when choosing transseptal approaches for clival chordoma.
  • Transnasal endoscopic skull base surgery may offer a reduced risk of tumor seeding compared to traditional transseptal methods.